Eli Lilly, Regeneron named to FDA pilot program to boost US drug manufacturing

Seeking Alpha ·

Eli Lilly ( LLY ) and Regeneron Pharmaceuticals ( REGN ) are among seven drug companies selected by the US FDA to become a part of the FDA PreCheck Pilot Program, which is designed to improve US drug manufacturing capabilities.

DYAX Investor Sentiment

Bullish (Long) 52% · Bearish (Short) 48%

544 participants

Related News

원문 보기 — Seeking Alpha